Secondary Immunodeficiency
2 clinical trials · Condition
◉ Watch Secondary Immunodeficiency
| Record | Firm | Date |
|---|---|---|
| A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma (NCT06980480) | Takeda | 2026-01-14 |
| Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment (NCT03677557) | Ottawa Hospital Research Institute | 2018-09-19 |
Track Secondary Immunodeficiency automatically
Every clearance here is in the API, with alerts when new ones post.